{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:55:59Z","timestamp":1781214959315,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The use of anticoagulants in patients increases the risk of intracranial hemorrhage (ICH). Our aim was to identify factors associated with cerebral hemorrhage in patients using anticoagulants and to develop a predictive model that would provide an effective tool for the clinical assessment of cerebral hemorrhage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In our study, indications for patients receiving anticoagulation included AF, VTE, stroke\/TIA, arteriosclerosis, peripheral vascular diseases (PVD), prosthetic mechanical valve replacement, etc. Data were obtained from the patient record hospitalization system. Logistic regression, area under the curve (AUC), and bar graphs were used to build predictive models in the development cohort. The models were internally validated, analytically characterized, and calibrated using AUC, calibration curves, and the Hosmer-Lemeshow test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This single-center retrospective study included 617 patients treated with anticoagulants. Multifactorial analysis showed that male, leukoaraiosis, high risk of falls, APTT\u202f\u2265\u202f45.4 s, and FIB\u202f\u2265\u202f4.2 g\/L were independent risk factors for cerebral hemorrhage, and <jats:italic>\u03b2<\/jats:italic>-blockers were protective factors. The model was constructed using these six factors with an AUC value of 0.883. In the validation cohort, the model had good discriminatory power (AUC\u202f=\u202f0.801) and calibration power. Five-fold cross-validation showed Kappa of 0.483.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Predictive models based on a patient\u2019s medical record hospitalization system can be used to identify patients at risk for cerebral hemorrhage. Identifying people at risk can provide proactive interventions for patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1475956","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:19:29Z","timestamp":1737523169000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A new score for predicting intracranial hemorrhage in patients using anticoagulant drugs"],"prefix":"10.3389","volume":"16","author":[{"given":"Fuxin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiana","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian atrial fibrillation anticoagulation (CAFA) study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1160\/TH11-11-0784","article-title":"Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study","volume":"107","author":"Banerjee","year":"2012","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of atrial fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cjca.2011.10.002","article-title":"Investigators of the registry of the Canadian stroke network. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the best practice for reinitiating anticoagulation therapy after intracranial bleeding (BRAIN) study","volume":"28","author":"Yung","year":"2012","journal-title":"Can J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/archinte.164.8.880","article-title":"The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage","volume":"164","author":"Rosand","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12325-022-02333-9","article-title":"Risk and Management of Bleeding Complications with direct Oral anticoagulants in patients with atrial fibrillation and venous thromboembolism: a narrative review","volume":"40","author":"Ballestri","year":"2023","journal-title":"Adv Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","article-title":"Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation","volume":"45","author":"Hankey","year":"2014","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"van","year":"2024","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"g4606","DOI":"10.1136\/bmj.g4606","article-title":"Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores","volume":"349","author":"Hippisley-Cox","year":"2014","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00277-024-05734-8","article-title":"A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs","volume":"103","author":"Ma","year":"2024","journal-title":"Ann Hematol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s12028-022-01671-4","article-title":"Risk factors for anticoagulant-associated intracranial hemorrhage: a systematic review and Meta-analysis","volume":"38","author":"Zeng","year":"2023","journal-title":"Neurocrit Care"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Subcommittee on control of anticoagulation of the scientific and standardization Committee of the International Society on thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1212\/01.WNL.0000142966.22886.20","article-title":"White matter lesions, cognition, and reurrent hemorrhage in lobar intracerebral hemorrhage","volume":"63","author":"Smith","year":"2004","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0895-4356(03)00047-7","article-title":"Internal and external validation of predictive models: a simulation study of bias and precision in small samples","volume":"56","author":"Steyerberg","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/MEG.0000000000002035","article-title":"Major gastrointestinal bleeding risk with direct oral anticoagulants: does type and dose matter?\u2014a systematic review and network meta-analysis","volume":"33","author":"Radadiya","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.preghy.2021.10.008","article-title":"Development and external validation of a model for predicting adverse outcomes in women with preeclampsia: a retrospective study from two trans-regional centers in China","volume":"26","author":"Sun","year":"2021","journal-title":"Pregnan Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijcard.2023.02.017","article-title":"New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulants","volume":"376","author":"Chen","year":"2023","journal-title":"Int J Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1212\/WNL.0000000000004289","article-title":"Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED","volume":"89","author":"Hilkens","year":"2017","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000453459","article-title":"Algra a; PERFORM and PRoFESS committees and investigators. The intracranial-B2LEED3S score and the risk of intracranial hemorrhage in ischemic stroke patients under antiplatelet treatment","volume":"43","author":"Amarenco","year":"2017","journal-title":"Cerebrovasc Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/STROKEAHA.120.031827","article-title":"Risk factors for intracerebral hemorrhage in patients with atrial fibrillation on non-vitamin K antagonist Oral anticoagulants for stroke prevention","volume":"52","author":"Paciaroni","year":"2021","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJM199710303371806","article-title":"Falls, injuries due to falls, and the risk of admission to a nursing home","volume":"337","author":"Tinetti","year":"1997","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1212\/WNL.53.6.1319","article-title":"Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke prevention in reversible ischemia trial (SPIRIT). European atrial fibrillation trial (EAFT) study groups","volume":"53","author":"Gorter","year":"1999","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cca.2020.04.022","article-title":"D-dimer\/fibrinogen ratio for the prediction of progressive hemorrhagic injury after traumatic brain injury","volume":"507","author":"Xu","year":"2020","journal-title":"Clin Chim Acta"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1161\/STROKEAHA.121.037009","article-title":"Association between Beta-blocker or statin drug use and the risk of hemorrhage from cerebral cavernous malformations","volume":"53","author":"Zuurbier","year":"2022","journal-title":"Stroke"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"qcac036","DOI":"10.1093\/ehjqcco\/qcac036","article-title":"Association between early Oral \u03b2-blocker therapy and risk for in-hospital major bleeding after percutaneous coronary intervention for acute coronary syndrome: Findings from CCC-ACS project [published online ahead of print, 2022 Jun 17]","author":"Xu","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1475956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:19:32Z","timestamp":1737523172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1475956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":30,"alternative-id":["10.3389\/fneur.2025.1475956"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1475956","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"article-number":"1475956"}}